UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Lowers Position in Cognex Corporation $CGNX

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC trimmed its position in shares of Cognex Corporation (NASDAQ:CGNX) by 10.2% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 976,599 shares of the scientific and technical instruments company’s stock after selling 110,365 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned approximately 0.58% of Cognex worth $70,725,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. BlackRock Inc. bought a new stake in shares of Cognex during the second quarter valued at approximately $1,158,123,000. Northwestern Mutual Wealth Management Co. raised its holdings in Cognex by 173,138.2% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 10,477,448 shares of the scientific and technical instruments company’s stock worth $376,979,000 after purchasing an additional 10,471,400 shares in the last quarter. Price T Rowe Associates Inc. MD raised its holdings in Cognex by 31.0% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 5,314,896 shares of the scientific and technical instruments company’s stock worth $191,231,000 after purchasing an additional 1,258,629 shares in the last quarter. Disciplined Growth Investors Inc. MN lifted its position in Cognex by 0.9% during the second quarter. Disciplined Growth Investors Inc. MN now owns 4,768,716 shares of the scientific and technical instruments company’s stock valued at $151,264,000 after buying an additional 40,927 shares during the period. Finally, Geode Capital Management LLC lifted its position in Cognex by 27.1% during the fourth quarter. Geode Capital Management LLC now owns 3,950,299 shares of the scientific and technical instruments company’s stock valued at $142,154,000 after buying an additional 842,783 shares during the period. Institutional investors own 88.12% of the company’s stock.

Analysts Set New Price Targets

CGNX has been the topic of a number of recent research reports. Barclays reaffirmed an “overweight” rating and issued a $80.00 target price (up from $75.00) on shares of Cognex in a research report on Monday, August 10th. The Goldman Sachs Group reissued a “buy” rating and set a $91.00 price objective on shares of Cognex in a research note on Friday, August 7th. JPMorgan Chase & Co. upgraded shares of Cognex from a “neutral” rating to an “overweight” rating and upped their price objective for the stock from $65.00 to $75.00 in a report on Tuesday, May 26th. Cantor Fitzgerald raised their target price on shares of Cognex from $76.00 to $84.00 and gave the company an “overweight” rating in a research note on Friday, August 7th. Finally, Seaport Research Partners set a $75.00 target price on shares of Cognex in a report on Tuesday, May 26th. Two equities research analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $75.64.

Cognex Trading Down 0.2%

Shares of CGNX opened at $59.94 on Thursday. The company has a market cap of $10.08 billion, a price-to-earnings ratio of 58.19 and a beta of 1.49. The business’s fifty day simple moving average is $64.14 and its two-hundred day simple moving average is $59.82. Cognex Corporation has a 12 month low of $34.60 and a 12 month high of $72.88.

Cognex (NASDAQ:CGNX) last posted its quarterly earnings results on Wednesday, August 5th. The scientific and technical instruments company reported $0.45 earnings per share for the quarter, topping the consensus estimate of $0.42 by $0.03. The firm had revenue of $291.26 million during the quarter, compared to analysts’ expectations of $292.10 million. Cognex had a return on equity of 13.50% and a net margin of 16.05%.The company’s revenue was up 16.9% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.25 earnings per share. Cognex has set its FY 2026 guidance at 1.640-1.680 EPS and its Q3 2026 guidance at 0.500-0.540 EPS. As a group, research analysts forecast that Cognex Corporation will post 1.68 EPS for the current year.

Cognex Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 3rd. Shareholders of record on Thursday, August 20th will be given a $0.085 dividend. The ex-dividend date of this dividend is Thursday, August 20th. This represents a $0.34 dividend on an annualized basis and a yield of 0.6%. Cognex’s payout ratio is 33.01%.

Cognex Profile

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.